Application of exosomes as liquid biopsy in clinical diagnosis

Biting Zhou, Kailun Xu, Xi Zheng, Ting Chen, Jian Wang, Yongmao Song, Yingkuan Shao, Shu Zheng, Biting Zhou, Kailun Xu, Xi Zheng, Ting Chen, Jian Wang, Yongmao Song, Yingkuan Shao, Shu Zheng

Abstract

Liquid biopsy refers to the sampling and molecular analysis of the biofluids of circulating tumor cells, extracellular vesicles, nucleic acids, and so forth. Exosomes are small extracellular vesicles with sizes between 30-150 nm. They are secreted by multivesicular bodies through exocytosis in live cells and can participate in intercellular communication due to their contents, including nucleic acids, proteins, and lipids. Herein, we investigate publication frequencies on exosomes over the past 10 years, and review recent clinical studies on liquid biopsy of exosomes in the fields of oncology, pregnancy disorders, cardiovascular diseases, and organ transplantation. We also describe the advantages of exosomes as an effective liquid biopsy tool and the progression of exosome extraction methods. Finally, we depict the commercial development of exosome research and discuss the future role of exosomes in liquid biopsy.

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Publication frequencies of studies investigating different contents of exosomes as liquid biopsy for disease diagnosis over the past 10 years based on the PubMed search, January 2020
Fig. 2
Fig. 2
Biogenesis, secretion, composition, and application of exosomes as liquid biopsy. Exosomes, originating from the endosomal pathway via the formation of late endosomes or multivesicular bodies, enclose a variable spectrum of molecules characterized by parent cells, including nucleic acids (DNA, mRNA, miRNA, lncRNA, circRNA, etc.), proteins, and lipids, which shows great promise in clinical applications in cancer, pregnancy disorders, cardiovascular diseases and organ transplantation
Fig. 3
Fig. 3
Exosomes in liver metastasis of colorectal cancer. Stromal cell-derived exosomes can carry bioactive molecules (e.g., miR-92a-3p) to CRC cells and enhance epithelial-mesenchymal transition and cell stemness to promote liver metastasis. Many other miRNAs (e.g., miR-193a, miR-21, miR-25-3p, miR-18a, miR-17-5p, miR-141-3p, miR-548c-5p, miR-375, and miR-6803-5p) encapsulated in exosomes from primary CRC cells, which flow to the liver via blood circulation and lead to liver metastasis, can be candidates for prognosis

References

    1. Yáñez-Mó M, et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles. 2015;4:27066.
    1. Théry C, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles. 2018;7:1535750–1535750.
    1. Johnstone RM, Adam M, Hammond JR, Orr L, Turbide C. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes) J. Biol. Chem. 1987;262:9412–9420.
    1. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C. Exosomal-like vesicles are present in human blood plasma. Int. Immunol. 2005;17:879–887.
    1. Pisitkun, T., Shen, R. F. & Knepper, M. A. Identification and proteomic profiling of exosomes in human urine. Proc. Natl Acad. Sci. USA101, 13368–13373 (2004).
    1. Street JM, et al. Identification and proteomic profiling of exosomes in human cerebrospinal fluid. J. Transl. Med. 2012;10:5.
    1. Palanisamy V, et al. Nanostructural and transcriptomic analyses of human saliva derived exosomes. PLoS ONE. 2010;5:e8577.
    1. Bard MP, et al. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am. J. Respir. Cell Mol. Biol. 2004;31:114–121.
    1. Runz S, et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol. Oncol. 2007;107:563–571.
    1. Keller S, et al. CD24 is a marker of exosomes secreted into urine and amniotic fluid. Kidney Int. 2007;72:1095–1102.
    1. Admyre C, et al. Exosomes with immune modulatory features are present in human breast milk. J. Immunol. 2007;179:1969–1978.
    1. Kulshreshtha A, Ahmad T, Agrawal A, Ghosh B. Proinflammatory role of epithelial cell-derived exosomes in allergic airway inflammation. J. Allergy Clin. Immunol. 2013;131:1194–1203.
    1. Jeppesen DK, et al. Reassessment of exosome composition. Cell. 2019;177:428–445.e418.
    1. Yokoi A, et al. Mechanisms of nuclear content loading to exosomes. Sci. Adv. 2019;5:eaax8849.
    1. Mathieu M, Martin-Jaular L, Lavieu G, Thery C. Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication. Nat. Cell Biol. 2019;21:9–17.
    1. Macias M, et al. Liquid biopsy: from basic research to clinical practice. Adv. Clin. Chem. 2018;83:73–119.
    1. Cheruvanky A, et al. Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. Am. J. Physiol. Renal Physiol. 2007;292:F1657–1661.
    1. Cheng Y, Zeng Q, Han Q, Xia W. Effect of pH, temperature and freezing-thawing on quantity changes and cellular uptake of exosomes. Protein Cell. 2019;10:295–299.
    1. Cai X, Janku F, Zhan Q, Fan JB. Accessing genetic information with liquid biopsies. Trends Genet. 2015;31:564–575.
    1. Xu R, Greening DW, Zhu H-J, Takahashi N, Simpson RJ. Extracellular vesicle isolation and characterization: toward clinical application. J. Clin. Investig. 2016;126:1152–1162.
    1. Théry C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat. Rev. Immunol. 2009;9:581–593.
    1. Tannetta D, Masliukaite I, Vatish M, Redman C, Sargent I. Update of syncytiotrophoblast derived extracellular vesicles in normal pregnancy and preeclampsia. J. Reprod. Immunol. 2017;119:98–106.
    1. Hoshino A, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329–335.
    1. Sun B, et al. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer. J. Cell. Physiol. 2019;234:1416–1425.
    1. Théry C, Amigorena S, Raposo G, Clayton A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. 2006;3:Unit 3.22.
    1. Tayoun T, et al. CTC-derived models: a window into the seeding capacity of circulating tumor cells (CTCs) Cells. 2019;8:1145.
    1. Fernando MR, Jiang C, Krzyzanowski GD, Ryan WL. New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes. PLoS ONE. 2017;12:e0183915.
    1. Keseru JS, et al. Detection of cell-free, exosomal and whole blood mitochondrial DNA copy number in plasma or whole blood of patients with serous epithelial ovarian cancer. J. Biotechnol. 2019;298:76–81.
    1. Allenson K, et al. High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients. Ann. Oncol. 2017;28:741–747.
    1. Mohrmann L, et al. Liquid biopsies using plasma exosomal nucleic acids and plasma cell-free DNA compared with clinical outcomes of patients with advanced cancers. Clin. Cancer Res. 2018;24:181–188.
    1. Wan Y, et al. Nanoscale extracellular vesicle-derived DNA is superior to circulating cell-free DNA for mutation detection in early-stage non-small-cell lung cancer. Ann. Oncol. 2018;29:2379–2383.
    1. Bernard, V. et al. Circulating nucleic acids associate with outcomes of patients with pancreatic cancer. Gastroenterology.156, 108–118 (2019).
    1. Tian X, Shen H, Li Z, Wang T, Wang S. Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment. J. Hematol. Oncol. 2019;12:84.
    1. Melo SA, et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature. 2015;523:177–182.
    1. Li J, et al. GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer. J. Cell. Mol. Med. 2017;21:838–847.
    1. Dong L, et al. Circulating long RNAs in serum extracellular vesicles: their characterization and potential application as biomarkers for diagnosis of colorectal cancer. Cancer Epidemiol. Biomark. Prev. 2016;25:1158–1166.
    1. Li S, et al. exoRBase: a database of circRNA, lncRNA and mRNA in human blood exosomes. Nucleic Acids Res. 2018;46:D106–d112.
    1. Castellanos-Rizaldos E, et al. Exosome-based detection of EGFR T790M in plasma from non–small cell lung cancer patients. Clin. Cancer Res. 2018;24:2944–2950.
    1. Sandfeld-Paulsen B, et al. Exosomal proteins as diagnostic biomarkers in lung cancer. J. Thorac. Oncol. 2016;11:1701–1710.
    1. Chen IH, et al. Phosphoproteins in extracellular vesicles as candidate markers for breast cancer. Proc. Natl Acad. Sci. USA. 2017;114:3175–3180.
    1. Krug AK, et al. Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma. Ann. Oncol. 2018;29:2143.
    1. Madhavan B, et al. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity. Int. J. Cancer. 2015;136:2616–2627.
    1. Street JM, Koritzinsky EH, Glispie DM, Star RA, Yuen PS. Urine exosomes: an emerging trove of biomarkers. Adv. Clin. Chem. 2017;78:103–122.
    1. Raimondo F, et al. Differential protein profiling of renal cell carcinoma urinary exosomes. Mol. Biosyst. 2013;9:1220–1233.
    1. Matsuzaki K, et al. MiR-21-5p in urinary extracellular vesicles is a novel biomarker of urothelial carcinoma. Oncotarget. 2017;8:24668–24678.
    1. Armstrong DA, Green BB, Seigne JD, Schned AR, Marsit CJ. MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer. Mol. Cancer. 2015;14:194.
    1. Keklikoglou I, et al. Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models. Nat. Cell Biol. 2019;21:190–202.
    1. Maji S, et al. Exosomal annexin II promotes angiogenesis and breast cancer metastasis. Mol. Cancer Res. 2017;15:93–105.
    1. Tiedemann K, et al. Exosomal release of L-plastin by breast cancer cells facilitates metastatic bone osteolysis. Transl. Oncol. 2019;12:462–474.
    1. Li L, et al. FLI1 exonic circular RNAs as a novel oncogenic driver to promote tumor metastasis in small cell lung cancer. Clin. Cancer Res. 2019;25:1302–1317.
    1. Bijnsdorp, I. V. et al. Exosomal ITGA3 interferes with non-cancerous prostate cell functions and is increased in urine exosomes of metastatic prostate cancer patients. J. Extracell. Vesicles.2, 1–10 (2013).
    1. Theodoraki MN, Yerneni SS, Hoffmann TK, Gooding WE, Whiteside TL. Clinical significance of PD-L1(+) exosomes in plasma of head and neck cancer patients. Clin. Cancer Res. 2018;24:896–905.
    1. Li C, et al. Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients. J. Transl. Med. 2019;17:355.
    1. Lux, A., Kahlert, C., Grützmann, R. & Pilarsky, C. c-Met and PD-L1 on circulating exosomes as diagnostic and prognostic markers for pancreatic cancer. Int. J. Mol. Sci.20, 3305 (2019).
    1. Teng Y, et al. MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression. Nat. Commun. 2017;8:14448.
    1. Zeng Z, et al. Cancer-derived exosomal miR-25-3p promotes pre-metastatic niche formation by inducing vascular permeability and angiogenesis. Nat. Commun. 2018;9:5395.
    1. Meltzer S, et al. Circulating exosomal miR-141-3p and miR-375 in metastatic progression of rectal cancer. Transl. Oncol. 2019;12:1038–1044.
    1. Hu JL, et al. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer. Mol. Cancer. 2019;18:91.
    1. Shao Y, et al. Colorectal cancer-derived small extracellular vesicles establish an inflammatory premetastatic niche in liver metastasis. Carcinogenesis. 2018;39:1368–1379.
    1. Fu F, Jiang W, Zhou L, Chen Z. Circulating exosomal miR-17-5p and miR-92a-3p predict pathologic stage and grade of colorectal cancer. Transl. Oncol. 2018;11:221–232.
    1. Peng, Z. Y., Gu, R. H. & Yan, B. Downregulation of exosome-encapsulated miR-548c-5p is associated with poor prognosis in colorectal cancer. J. Cell. Biochem.120, 1457–1463 (2018).
    1. Wei Y, et al. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Res. Treat. 2014;147:423–431.
    1. Mashouri L, et al. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol. Cancer. 2019;18:75.
    1. Wei F, et al. Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p. Mol. Cancer. 2017;16:132.
    1. Qu L, et al. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 2016;29:653–668.
    1. Liu T, et al. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer. Mol. Cancer. 2019;18:43–43.
    1. Han M, et al. Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer. Cell Death Dis. 2020;11:43.
    1. Shedden K, Xie XT, Chandaroy P, Chang YT, Rosania GR. Expulsion of small molecules in vesicles shed by cancer cells: association with gene expression and chemosensitivity profiles. Cancer Res. 2003;63:4331–4337.
    1. Sharma A. Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity. Nanomedicine (Lond., Engl.) 2017;12:2137–2148.
    1. Zheng P, et al. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells. J. Exp. Clin. Cancer Res. 2017;36:53.
    1. Binenbaum Y, et al. Transfer of miRNA in macrophage-derived exosomes induces drug resistance in pancreatic adenocarcinoma. Cancer Res. 2018;78:5287–5299.
    1. Chen G, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018;560:382–386.
    1. Salomon C, Scholz K, Kobayashi M. Hypoxia regulates the response of trophoblast-derived exosomes to hyperglycemia and displays a difference placental exosome profile in plasma from patients with gestational diabetes mellitus. Reprod. Sci. 2015;22:257–258.
    1. American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet. Gynecol. 2013;122:1122–1131.
    1. Mol BWJ, et al. Pre-eclampsia. Lancet (Lond., Engl.) 2016;387:999–1011.
    1. Salomon C, et al. Hypoxia-induced changes in the bioactivity of cytotrophoblast-derived exosomes. PLoS ONE. 2013;8:e79636.
    1. Dragovic RA, et al. Isolation of syncytiotrophoblast microvesicles and exosomes and their characterisation by multicolour flow cytometry and fluorescence nanoparticle tracking analysis. Methods (San. Diego, Calif.) 2015;87:64–74.
    1. Salomon C, et al. A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migration. PLoS ONE. 2014;9:e98667.
    1. Pillay P, Maharaj N, Moodley J, Mackraj I. Placental exosomes and pre-eclampsia: maternal circulating levels in normal pregnancies and, early and late onset pre-eclamptic pregnancies. Placenta. 2016;46:18–25.
    1. Biro O, et al. Various levels of circulating exosomal total-miRNA and miR-210 hypoxamiR in different forms of pregnancy hypertension. Pregnancy Hypertens. 2017;10:207–212.
    1. Salomon C, et al. Placental exosomes as early biomarker of preeclampsia: potential role of exosomal microRNAs across gestation. J. Clin. Endocrinol. Metab. 2017;102:3182–3194.
    1. Barbour LA, et al. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care. 2007;30:S112–119.
    1. Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin. Obstet. Gynecol. 2007;50:938–948.
    1. American Diabetes Association. Standards of medical care in diabetes–2014. Diabetes Care37, Suppl 1, S14–80, 10.2337/dc14-S014 (2014).
    1. Simmons D. in A Practical Manual of Diabetes in Pregnancy (eds McCance D., Maresh, M., Sacks D. A.) (London: Blackwell Publishing, London, 2010).
    1. Chu SY, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007;30:2070–2076.
    1. Mitchell MD, et al. Placental exosomes in normal and complicated pregnancy. Am. J. Obstet. Gynecol. 2015;213:S173–181.
    1. Salomon C, et al. Gestational diabetes mellitus is associated with changes in the concentration and bioactivity of placenta-derived exosomes in maternal circulation across gestation. Diabetes. 2016;65:598–609.
    1. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet (Lond., Engl.) 2009;373:1773–1779.
    1. Miranda J, et al. Placental exosomes profile in maternal and fetal circulation in intrauterine growth restriction -Liquid biopsies to monitoring fetal growth. Placenta. 2018;64:34–43.
    1. Xie J, et al. The relationship between amniotic fluid miRNAs and congenital obstructive nephropathy. Am. J. Transl. Res. 2017;9:1754–1763.
    1. Menon, R. et al. Circulating exosomal miRNA profile during term and preterm birth pregnancies-a longitudinal study. Endocrinology, 160, 249–275 (2018).
    1. Jiang PY, et al. MicroRNAs derived from urinary exosomes act as novel biomarkers in the diagnosis of intrahepatic cholestasis of pregnancy. Am. J. Transl. Res. 2019;11:6249–6261.
    1. Nielsen MR, et al. Urine exosomes from healthy and hypertensive pregnancies display elevated level of α-subunit and cleaved α- and γ-subunits of the epithelial sodium channel-ENaC. Pflug. Arch. 2017;469:1107–1119.
    1. Ghafarian F, et al. The clinical impact of exosomes in cardiovascular disorders: from basic science to clinical application. J. Cell. Physiol. 2019;234:12226–12236.
    1. Howard BV, et al. LDL cholesterol as a strong predictor of coronary heart disease in diabetic individuals with insulin resistance and low LDL: The Strong Heart Study. Arterioscler. Thromb. Vasc. Biol. 2000;20:830–835.
    1. Ndrepepa G, et al. High-sensitivity troponin T and mortality after elective percutaneous coronary intervention. J. Am. Coll. Cardiol. 2016;68:2259–2268.
    1. Wang K, et al. Enhanced cardioprotection by human endometrium mesenchymal stem cells driven by exosomal MicroRNA-21. Stem Cells Transl. Med. 2017;6:209–222.
    1. Ong SG, et al. Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal microRNA transfer. Circulation. 2014;130:S60–69.
    1. Emanueli C, Shearn AI, Angelini GD, Sahoo S. Exosomes and exosomal miRNAs in cardiovascular protection and repair. Vasc. Pharmacol. 2015;71:24–30.
    1. Kuwabara Y, et al. Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ. Cardiovasc. Genet. 2011;4:446–454.
    1. Ibrahim AG, Cheng K, Marban E. Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep. 2014;2:606–619.
    1. Barile L, et al. Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc. Res. 2014;103:530–541.
    1. Saha, P. et al. Circulating exosomes derived from transplanted progenitor cells aid the functional recovery of ischemic myocardium. Sci. Transl. Med.11, eaau1168 (2019).
    1. Chen L, et al. Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury. Biochem. Biophys. Res. Commun. 2013;431:566–571.
    1. Liu Y, et al. Atherosclerotic conditions promote the packaging of functional MicroRNA-92a-3p into endothelial microvesicles. Circulation Res. 2019;124:575–587.
    1. Li H, et al. Coronary serum exosomes derived from patients with myocardial ischemia regulate angiogenesis through the miR-939-mediated nitric oxide signaling pathway. Theranostics. 2018;8:2079–2093.
    1. Christersson C, Thulin A, Siegbahn A. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events. Thromb. Haemost. 2017;117:1571–1581.
    1. Chiva-Blanch G, et al. CD3(+)/CD45(+) and SMA-alpha(+) circulating microparticles are increased in individuals at high cardiovascular risk who will develop a major cardiovascular event. Int. J. Cardiol. 2016;208:147–149.
    1. Kanhai DA, et al. Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease. Int. J. Cardiol. 2013;168:2358–2363.
    1. Cheow ES, et al. Plasma-derived extracellular vesicles contain predictive biomarkers and potential therapeutic targets for myocardial ischemic (MI) injury. Mol. Cell. Proteom. 2016;15:2628–2640.
    1. Goren Y, et al. Serum levels of microRNAs in patients with heart failure. Eur. J. Heart Fail. 2012;14:147–154.
    1. Matsumoto S, et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circulation Res. 2013;113:322–326.
    1. Berezin AE, et al. Predictive value of apoptotic microparticles to mononuclear progenitor cells ratio in advanced chronic heart failure patients. J. Cardiol. 2015;65:403–411.
    1. Ji Q, et al. Increased brain-specific MiR-9 and MiR-124 in the serum exosomes of acute ischemic stroke patients. PLoS ONE. 2016;11:e0163645.
    1. Halkein J, et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J. Clin. Investig. 2013;123:2143–2154.
    1. Vandergriff AC, et al. Intravenous cardiac stem cell-derived exosomes ameliorate cardiac dysfunction in doxorubicin induced dilated cardiomyopathy. Stem Cells Int. 2015;2015:960926.
    1. Wang H, et al. Increased serum levels of microvesicles in nonvalvular atrial fibrillation determinated by ELISA using a specific monoclonal antibody AD-1. Clin. Chim. Acta. 2010;411:1700–1704.
    1. Kasner M, et al. Circulating exosomal microRNAs predict functional recovery after MitraClip repair of severe mitral regurgitation. Int. J. Cardiol. 2016;215:402–405.
    1. Benichou G, Valujskikh A, Heeger PS. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J. Immunol. 1999;162:352–358.
    1. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. Immunologic ‘ignorance’ of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat. Med. 2000;6:686–688.
    1. Liu Q, et al. Donor dendritic cell-derived exosomes promote allograft-targeting immune response. J. Clin. Investig. 2016;126:2805–2820.
    1. Morelli AE, Bracamonte-Baran W, Burlingham WJ. Donor-derived exosomes: the trick behind the semidirect pathway of allorecognition. Curr. Opin. Organ Transplant. 2017;22:46–54.
    1. Gonzalez-Nolasco B, Wang M, Prunevieille A, Benichou G. Emerging role of exosomes in allorecognition and allograft rejection. Curr. Opin. Organ Transplant. 2018;23:22–27.
    1. Vallabhajosyula P, et al. Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue. J. Clin. Investig. 2017;127:1375–1391.
    1. Gunasekaran M, et al. Donor-derived exosomes with lung self-antigens in human lung allograft rejection. Am. J. Transplant. 2017;17:474–484.
    1. Gregson AL, et al. Altered exosomal RNA profiles in bronchoalveolar lavage from lung transplants with acute rejection. Am. J. Respir. Crit. Care Med. 2015;192:1490–1503.
    1. Kennel PJ, et al. Serum exosomal protein profiling for the non-invasive detection of cardiac allograft rejection. J. Heart Lung Transplant. 2018;37:409–417.
    1. Sukma Dewi I, et al. Exosomal miR-142-3p is increased during cardiac allograft rejection and augments vascular permeability through down-regulation of endothelial RAB11FIP2 expression. Cardiovasc. Res. 2017;113:440–452.
    1. Park J, et al. Integrated kidney exosome analysis for the detection of kidney transplant rejection. ACS Nano. 2017;11:11041–11046.
    1. Lim JH, et al. Novel urinary exosomal biomarkers of acute T cell-mediated rejection in kidney transplant recipients: a cross-sectional study. PLoS ONE. 2018;13:e0204204.
    1. Zhang H, et al. Plasma exosomes from HLA-sensitized kidney transplant recipients contain mRNA transcripts which predict development of antibody-mediated rejection. Transplantation. 2017;101:2419–2428.
    1. Korutla, L. et al. Noninvasive diagnosis of recurrent autoimmune type 1 diabetes after islet cell transplantation. Am. J. Transplant.19, 1852–1858 (2019).
    1. Gardiner C, et al. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J. Extracell. Vesicles. 2016;5:32945.
    1. Brennan K, et al. A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. Sci. Rep. 2020;10:1039.
    1. Mateescu B, et al. Obstacles and opportunities in the functional analysis of extracellular vesicle RNA–an ISEV position paper. J. Extracell. Vesicles. 2017;6:1286095.
    1. Webber, J. & Clayton, A. How pure are your vesicles? J Extracell Vesicles2, 19861 (2013).
    1. Tian Y, et al. Quality and efficiency assessment of six extracellular vesicle isolation methods by nano-flow cytometry. J. Extracell. Vesicles. 2020;9:1697028.
    1. Van Deun J, et al. EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat. Methods. 2017;14:228–232.
    1. Simonsen JB. What are we looking at? extracellular vesicles, lipoproteins, or both? Circ. Res. 2017;121:920–922.
    1. Flaherty SE, III, et al. A lipase-independent pathway of lipid release and immune modulation by adipocytes. Science. 2019;363:989–993.
    1. Takov K, Yellon DM, Davidson SM. Comparison of small extracellular vesicles isolated from plasma by ultracentrifugation or size-exclusion chromatography: yield, purity and functional potential. J. Extracell. Vesicles. 2019;8:1560809.
    1. Lobb RJ, et al. Optimized exosome isolation protocol for cell culture supernatant and human plasma. J. Extracell. Vesicles. 2015;4:27031.
    1. Sódar BW, et al. Low-density lipoprotein mimics blood plasma-derived exosomes and microvesicles during isolation and detection. Sci. Rep. 2016;6:24316.
    1. Zheng X, et al. A circulating extracellular vesicles-based novel screening tool for colorectal cancer revealed by shotgun and data-independent acquisition mass spectrometry. J. Extracell. Vesicles. 2020;9:1750202.
    1. Schmelter C, et al. Comparison of two solid-phase extraction (SPE) methods for the identification and quantification of porcine retinal protein markers by LC-MS/MS. Int. J. Mol. Sci. 2018;19:3847.
    1. Fang S, et al. Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification. PLoS ONE. 2017;12:e0175050.
    1. Dorayappan, K. D. P. et al. A microfluidic chip enables isolation of exosomes and establishment of their protein profiles and associated signaling pathways in ovarian cancer. Cancer Res.79, 3503–3513 (2019).
    1. Zarovni N, et al. Integrated isolation and quantitative analysis of exosome shuttled proteins and nucleic acids using immunocapture approaches. Methods (San. Diego, Calif.) 2015;87:46–58.
    1. Woo HK, et al. Urine-based liquid biopsy: non-invasive and sensitive AR-V7 detection in urinary EVs from patients with prostate cancer. Lab Chip. 2018;19:87–97.
    1. Ghosh A, et al. Rapid isolation of extracellular vesicles from cell culture and biological fluids using a synthetic peptide with specific affinity for heat shock proteins. PLoS ONE. 2014;9:e110443.
    1. Bijnsdorp IV, et al. Feasibility of urinary extracellular vesicle proteome profiling using a robust and simple, clinically applicable isolation method. J. Extracell. Vesicles. 2017;6:1313091.
    1. Liu F, et al. The exosome total isolation chip. ACS Nano. 2017;11:10712–10723.
    1. Chen J, Xu Y, Lu Y, Xing W. Isolation and visible detection of tumor-derived exosomes from plasma. Anal. Chem. 2018;90:14207–14215.
    1. Alegre E, et al. Study of circulating microRNA-125b levels in serum exosomes in advanced melanoma. Arch. Pathol. Lab. Med. 2014;138:828–832.
    1. Sáenz-Cuesta M, et al. Methods for extracellular vesicles isolation in a hospital setting. Front. Immunol. 2015;6:50.
    1. Knol JC, et al. Peptide-mediated ‘miniprep’ isolation of extracellular vesicles is suitable for high-throughput proteomics. EuPA Open Proteom. 2016;11:11–15.
    1. Welton JL, Webber JP, Botos LA, Jones M, Clayton A. Ready-made chromatography columns for extracellular vesicle isolation from plasma. J. Extracell. Vesicles. 2015;4:27269.
    1. Rim KT, Kim SJ. Quantitative analysis of exosomes from murine lung cancer cells by flow cytometry. J. Cancer Prev. 2016;21:194–200.
    1. Zhao L, et al. Isolation and Identification of miRNAs in exosomes derived from serum of colon cancer patients. J. Cancer. 2017;8:1145–1152.
    1. Soares Martins T, Catita J, Martins Rosa I, da Cruz E Silva OAB, Henriques AG. Exosome isolation from distinct biofluids using precipitation and column-based approaches. PLoS ONE. 2018;13:e0198820.
    1. Kevin Dooley, S. C. J. et al. Developing an Engineered Exosome Therapeutic Platform for Immuno-Oncology. Keystone Symposium on Cancer Immunotherapy, Whistler, Canada (2019).
    1. McKiernan J, et al. A prospective adaptive utility trial to validate performance of a novel urine exosome gene expression assay to predict high-grade prostate cancer in patients with prostate-specific antigen 2-10ng/ml at initial biopsy. Eur. Urol. 2018;74:731–738.
    1. McKiernan J, et al. A novel urine exosome gene expression assay to predict high-grade prostate cancer at initial biopsy. JAMA Oncol. 2016;2:882–889.
    1. Avalon GloboCare and its Subsidiary Genexosome Technologies Announce Discovery and Development of World’s First Saliva-Based Exosomal Biomarker “miR-185” as Dual Diagnostic and Therapeutic Target for Oral Cancer. GLOBE NEWSWIRE. (Accessed 28 Jan 2019).
    1. Avalon GloboCare Announces Breakthrough in Identifying Human Angiogenic Exosomes/Extracellular Vesicles (EV) Derived from Endothelial Cells. GLOBE NEWSWIRE. (Accessed 11 Feb 2019).
    1. PureTech Health Announces Collaboration with Roche to Advance Technology for Oral Administration of Antisense Oligonucleotides. PureTech News. (Accessed 20 Jul 2018).
    1. Agrawal AK, et al. Milk-derived exosomes for oral delivery of paclitaxel. Nanomed. Nanotechnol. Biol. Med. 2017;13:1627–1636.
    1. Figueroa JM, et al. Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patients. Neuro Oncol. 2017;19:1494–1502.
    1. Kimura, H. et al. CKAP4, a DKK1 Receptor, is a biomarker in exosomes derived from pancreatic cancer and a molecular target for therapy. Clin. Cancer Res. 25, 1936–1947 (2019).
    1. Yokoyama S, et al. Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction-Measurement by ELISA. PLoS ONE. 2017;12:e0183337.
    1. Rodriguez M, et al. Different exosome cargo from plasma/bronchoalveolar lavage in non-small-cell lung cancer. Genes Chromosomes Cancer. 2014;53:713–724.
    1. Niu L, et al. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer. Cancer Sci. 2019;110:433–442.
    1. Hannafon BN, et al. Plasma exosome microRNAs are indicative of breast cancer. Breast Cancer Res. 2016;18:90.
    1. Zhou W, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell. 2014;25:501–515.
    1. Wang, X. et al. Exosomal protein CD82 as a diagnostic biomarker for precision medicine for breast cancer. Mol carcinogen, 58, 674–685 (2019).
    1. Arbelaiz A, et al. Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. Hepatology. 2017;66:1125–1143.
    1. Matsumura T, et al. Exosomal microRNA in serum is a novel biomarker of recurrence in human colorectal cancer. Br. J. Cancer. 2015;113:275–281.
    1. Sandfeld-Paulsen B, et al. Exosomal proteins as prognostic biomarkers in non-small cell lung cancer. Mol. Oncol. 2016;10:1595–1602.
    1. Taverna S, et al. Amphiregulin contained in NSCLC-exosomes induces osteoclast differentiation through the activation of EGFR pathway. Sci. Rep. 2017;7:3170.
    1. Rodríguez-Martínez A, et al. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy. Breast Cancer Res. 2019;21:21.
    1. Alegre E, et al. Circulating melanoma exosomes as diagnostic and prognosis biomarkers. Clin. Chim. Acta. 2016;454:28–32.
    1. Lin, Y. et al. Evaluation of salivary exosomal chimeric GOLM1-NAA35 RNA as a potential biomarker in esophageal carcinoma. Clin. Cancer Res.25, 3035–3045 (2019).
    1. Stokman MF, et al. Changes in the urinary extracellular vesicle proteome are associated with nephronophthisis-related ciliopathies. J. Proteom. 2019;192:27–36.
    1. Hisey CL, Dorayappan KDP, Cohn DE, Selvendiran K, Hansford DJ. Microfluidic affinity separation chip for selective capture and release of label-free ovarian cancer exosomes. Lab Chip. 2018;18:3144–3153.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다